Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Bacterial Infections

Explore clinical trials studying Central Nervous System Bacterial Infections. Study availability and eligibility vary by location and protocol.

178 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Bacterial Infections trial results

Completed

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

NCT03476135

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Sanofi Pasteur Investigational Site 2460005 Espoo, Finland
  • Sanofi Pasteur Investigational Site 2460006 Helsinki, Finland
  • Sanofi Pasteur Investigational Site 2460002 Helsinki, Finland
  • Sanofi Pasteur Investigational Site 2460007 Jarvenpaa, Finland
View Trial Details
Completed

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

NCT02842853

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham, Alabama, United States
  • Dothan, Alabama, United States
  • Mobile, Alabama, United States
  • Glendale, Arizona, United States
View all 89 locations
View Trial Details
Completed

Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

NCT02752906

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Number 016 Birmingham, Alabama, United States
  • Investigational Site Number 032 Dothan, Alabama, United States
  • Investigational Site Number 026 Mesa, Arizona, United States
  • Investigational Site Number 022 Jonesboro, Arkansas, United States
View all 30 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

NCT02842866

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Chandler, Arizona, United States
  • Anaheim, California, United States
  • San Diego, California, United States
  • Waterbury, Connecticut, United States
View all 36 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

NCT02955797

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site 309 Espoo, Finland
  • Investigational Site 301 Helsinki, Finland
  • Investigational Site 306 Helsinki, Finland
  • Investigational Site 302 Jarvenpaa, Finland
View all 33 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT03205358

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Number 005 Espoo, Finland
  • Investigational Site Number 006 Helsinki, Finland
  • Investigational Site Number 002 Helsinki, Finland
  • Investigational Site Number 007 Jarvenpaa, Finland
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

NCT02199691

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Downey, California, United States
  • San Diego, California, United States
View all 36 locations
View Trial Details

Related conditions